BICTEGRAVIR SODIUM

UNII:	4L5MP1Y7W7
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₁H₁₇F₃N₃O₅.Na
Preferred Substance Name:	BICTEGRAVIR SODIUM
InChIKey:	WJNFBIVCQMPPJC-FQYDJHLKSA-M
GSRS Full Record:	4L5MP1Y7W7 i

1807988-02-8
(2R,5S,13aR)-8-hydroxy-7,9-dioxo-N-[(2,4,6-trifluorophenyl)methyl]-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide monosodium salt
2,5-Methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide, 2,3,4,5,7,9,13,13a-octahydro-8-hydroxy-7,9-dioxo-N-[(2,4,6-trifluorophenyl)methyl]-, sodium salt (1:1), (2R,5S,13aR)-
BICTEGRAVIR SODIUM [JAN]
BICTEGRAVIR SODIUM [MI]
BICTEGRAVIR SODIUM [ORANGE BOOK]
BICTEGRAVIR SODIUM [USAN]
BIKTARVY COMPONENT BICTEGRAVIR SODIUM
Bictegravir Sodium
Bictegravir sodium [WHO-DD]
GS-9883 SODIUM
GS-9883-01 SODIUM

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

BICTEGRAVIR SODIUM

Synonyms and Mappings

Resources